Abstract:Abstract Background Phage display technology is a powerful new tool for making antibodies outside the immune system, thus avoiding the use of experimental animals. In the early days, it was postulated that this technique would eventually replace hybridoma technology and animal immunisations. However, since this technology emerged more than 20 years ago, there have only been a handful reports on the construction and application of phage display antibody libraries world-wide. Results Here we report the simplest and highly efficient method for the construction of a highly useful human single chain variable fragment (scFv) library. The least number of oligonucleotide primers, electroporations and ligation reactions were used to generate a library of 1.5 × 10 8 individual clones, without generation of sub-libraries. All possible combinations of heavy and light chains, among all immunoglobulin isotypes, were included by using a mixture of primers and overlapping extension PCR. The key difference from other similar libraries was the highest diversity of variable gene repertoires, which was derived from 140 non-immunized human donors. A wide variety of antigens were successfully used to affinity select specific binders. These included pure recombinant proteins, a hapten and complex antigens such as viral coat proteins, crude snake venom and cancer cell surface antigens. In particular, we were able to use standard bio-panning method to isolate antibody that can bind to soluble Aflatoxin B1, when using BSA-conjugated toxin as a target, as demonstrated by inhibition ELISA. Conclusion These results suggested that by using an optimized protocol and very high repertoire diversity, a compact and efficient phage antibody library can be generated. This advanced method could be adopted by any molecular biology laboratory to generate both naïve or immunized libraries for particular targets as well as for high-throughput applications.

Phage Display of Random Combinatorial Libraries of Ig-Binding Mono-Domains of Protein A and Protein L and Ig Affinity Screening

Use of Baculovirus MHC/peptide Display Libraries to Characterize T‐cell Receptor Ligands

A Simple Whole-Plasmid PCR Method to Construct High-Diversity Synthetic Phage Display Libraries

Advances in Studies on Phage Display Systems

Protein Iii-Based Single-Chain Antibody Phage Display Using Bacterial Cells Bearing an Additional Genome of A Gene-Iii-Lacking Helper Phage

Selection of the Peptides Binding to ICAM-1 from Phage Display Random 15mer Peptide Library

A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single‐chain antibody fragments

A compact phage display human scFv library for selection of antibodies to a wide variety of antigens

Semisynthetic Phage Display Library Construction: Design and Synthesis of Diversified Single-Chain Variable Fragments and Generation of Primary Libraries

A Novel Strategy for Proteome-wide Ligand Screening Using Cross-linked Phage Matrices

Generation of Antibody Libraries for Phage Display: Human Fab Format

Generation of a Large Peptide Phage Display Library by Self-Ligation of Whole-Plasmid PCR Product

A Single-Chain Antibody Using LoxP511 as the Linker Enables Large-Content Phage Library Construction via Cre/LoxP Recombination

Construction and Diversity Analysis of a Na(i)ve Human Phage-Displayed Fab Library

Phages Displaying Peptides with Beta Turn Conformation.

Construction of a large phage display antibody library by in vitro package and in vivo recombination

Generation of Antibody Libraries for Phage Display: Library Reamplification

The role of phage display in therapeutic antibody discovery

Generation and Next-Generation Sequencing-Based Characterization of a Large Human Combinatorial Antibody Library

Advancement in the development of single chain antibodies using phage display technology

Construction of a Large Size Human Immunoglobulin Heavy Chain Variable (VH) Domain Library, Isolation and Characterization of Novel Human Antibody VH Domains Targeting PD-L1 and CD22